cytarabine การใช้

• Other cell division inhibitors commonly used in studies are cytarabine and temozolomide.
• It is testing midostaurin in combination with daunorubicin and cytarabine.
• In combination, intrathecal chemotherapy most often comprises methotrexate, cytarabine, thiotepa and steroids.
• Course B consists of methotrexate and cytarabine.
• In traditional chemotherapy for AML, physicians administer the two drugs daunorubicin and cytarabine for one week.
• It has given encouraging results in a phase II trial for myelodysplastic syndromes in combination with idarubicin and cytarabine.
• Consistent with this, leukemia patients respond better to cytarabine treatments given every 12 hours rather than every 24 hours.
• The deoxynucleoside analogues include cytarabine, gemcitabine, decitabine, Vidaza, fludarabine, nelarabine, cladribine, clofarabine and pentostatin.
• These include : Bleomycin, chlorambucil, cyclophosphamide, cytarabine, doxorubicin, lomustine, mitoxantrone, topotecan, and vincristine.
• In the new study, researchers added a higher dose of one of the drugs, cytarabine, for three additional days.
• These compounds led to the synthesis of a new generation, sugar modified nucleoside analog vidarabine, and the related compound cytarabine.
• NEH was first described in 1982 in a patient with acute myeloid leukaemia ( AML ) who had received cytarabine as chemotherapy.
• The discovery of these nucleosides also led to the development of cytarabine for clinical use in the treatment of leukemia and lymphoma.
• Cytarabine, a DNA-synthesis inhibitor also known as ara-C, is cited as the classic cell cycle phase-specific agent.
• Currently, anthracyclines, cytarabine and etoposide are widely used in the treatment of AML due to their ability to induce apoptosis in leukemic cells.
• Another is a combination trial of glasdenib with ARA-C, decitabine, daunorubicin, or cytarabine for the treatment of acute myeloid leukemia.
• The patient was prescribed six oral drugs, intrathecal cytarabine and intravenous vincristine by another doctor, and was injected by the trainee later the day.
• It produces generics of intravenous oncology products such as Paclitaxel, Irinotecan, Oxaliplatin, Gemcitabine, Cytarabine, Carboplatin, Topotecan, Docetaxel and Epirubicin.
• Gemcitabine, a fluorinated derivative of cytarabine, is used to treat pancreatic, breast, bladder, and non-small-cell lung cancer.
• The drug is a time-release formulation of a common chemotherapeutic drug known as cytarabine, potentially offering the benefits of the drug with fewer injections.